If there’s one constant with software developers, it is that sometimes they get bored. At these times, they tend to think ...
SINGAPORE & OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) will present data from two global Phase 3 double-blind, placebo-controlled studies of oveporexton (TAK-861) 1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback